Principal Scientist II - Biotherapeutic Engineering & Conjugation (BEC) (80-100%*)

Summary

Novartis' Biomedical Research division is the innovation engine of Novartis, focusing on new technologies that have the potential to help produce therapeutic breakthroughs for patients. The Biotherapeutic Engineering and Conjugation (BEC) group is a part of...